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Developmental and Regional Changes in the
Neurochemical Profile of the Rat Brain Determined by In
Vivo 1H NMR Spectroscopy
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Sixteen metabolites were quantified from 11–24 l volumes in
three different brain regions (hippocampus, striatum, and cere-
bral cortex) during postnatal development. Rat pups from the
same litter were repeatedly measured on postnatal days 7, 10,
14, 21, and 28 using a completely noninvasive and longitudinal
study design. Metabolite quantification was based on ultra-
short echo-time 1H NMR spectroscopy at 9.4 T and LCModel
processing. Most of the brain metabolites were quantified with
Cramer-Rao lower bounds (CRLB) less than 20%, which corre-
sponded to an estimated concentration error <0.2 mol/g. Tau-
rine and total creatine were quantified with CRLB ≤ 5% from all
114 processed spectra. The resulting high reliability and repro-
ducibility revealed significant regional and age-related changes
in metabolite concentrations. The most sensitive markers for
developmental and regional variations between hippocampus,
striatum, and cerebral cortex were N-acetylaspartate, myo-ino-
sitol, taurine, glutamate, and choline compounds. Absolute val-
ues of metabolite concentrations were in very good agreement
with previously published in vitro results based on chromato-
graphic measurements of brain extracts. The current data may
serve as a reference for studies focused on developmental
defects and pathologies using neonatal rat models. Magn
Reson Med 50:24–32, 2003. © 2003 Wiley-Liss, Inc.
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The late fetal and early neonatal periods in humans can be
evaluated by MR techniques, which reveal that significant
regional changes in brain structure (1), function (2), and
neurochemistry (3) occur over time. The rat brain between
postnatal days 7 and 28 (P7–P28) is an established model
for studies of early human brain development, where the
P7 animal corresponds neurodevelopmentally to the hu-
man fetus at 34 weeks gestation and the P28 animal to a
2–3-year-old human infant (4). This rapid postnatal devel-
opment is associated with substantial biochemical
changes (5–7) that in the past were assessed using in vitro
methods based on sacrificing the animals at different post-
natal ages. Typically, extracts of the removed brains were
analyzed by chromatographic methods or NMR spectros-
copy (8–11). Noninvasive in vivo 1H and 31P NMR spec-
troscopy have been used as well for developmental studies
of the rat brain. However, only concentration ratios of a
limited number of metabolites such as N-acetylaspartate,
choline, creatine, phosphocreatine, and phosphoryleth-
anolamine (12–14) were measured. Furthermore, the spec-
tra were taken from large volumes containing the majority
of the brain tissue, without taking into account regional
biochemical variations.
Recently, we have shown that at least 18 metabolites
(“neurochemical profile”) can be quantified noninvasively
in adult rat brain using highly spectrally and spatially
resolved 1H NMR spectroscopy at 9.4 T, based on FAST-
MAP shimming (15,16), high-performance ultra-short
echo-time localization (17), and LCModel spectral analysis
(18). The purpose of the present study was to comprehen-
sively measure the developmental changes of metabolite
concentrations in three different regions of the neonatal rat
brain using a completely noninvasive longitudinal study
design. The hippocampus and the striatum were chosen
because of their central roles in recognition and proce-
dural memory functions, respectively, and the cerebral
cortex was selected due to its involvement in higher exec-
utive functions. These areas are hypothesized to be selec-
tively vulnerable to neonatal insults (19,20). The develop-
ing rat brain with its large range of metabolite concentra-
tion changes served as a suitable model to test and validate
used spectroscopic technique and the method of quantifi-
cation.
MATERIALS AND METHODS
Animals
Experiments were performed according to procedures ap-
proved by the Institutional Animal Care and Use Commit-
tee. Pregnant Sprague-Dawley dams were housed in the
local animal facility to exactly determine the day of birth.
The number of pups in a litter was randomly culled to
eight soon after birth. The body weight of the rat pups
increased with age (mean  SD): 15  2 g (P7), 23  3 g
(P10), 34  3 g (P14), 56  4 g (P21), 85  6 g (P28).
Spontaneously breathing rats were fixed in a chamber and
anesthetized by flow of a gas mixture (N2O:O2  1:1)
containing 1.5–2% isoflurane. The air temperature sur-
rounding the rat chamber was maintained at 30°C by warm
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water circulation and verified by a thermosensor. The du-
ration of a study of a single animal did not exceed 100 min.
The experiments were performed longitudinally, i.e., the
rat pups were measured repeatedly over the first
4 postnatal weeks. Two litters were used to study the
hippocampus, striatum, and cerebral cortex, resulting in
5–9 measurements per brain location per postnatal day.
An additional litter was used to measure spectra from
FIG. 1. RARE images of a rat brain (7) with the volumes of interest (VOI) centered in striatum, cortex, and hippocampus selected for NMR
spectroscopy studies. ETL  8, TE  48 ms, matrix  256  256, slice thickness  1 mm.
FIG. 2. In vivo 1H NMR spectra of the de-
veloping rat hippocampus (P7–P28).
STEAM, TE  2 ms, TM  20 ms, TR 
5 sec, NT  320, VOI  11–18 l. Process-
ing: Gaussian multiplication (gf  0.12,
gfs  0.05), FT, and zero-order phase cor-
rection. No water signal removal or baseline
corrections were applied.
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hippocampus only, resulting in 9–12 measurements per
postnatal day in that brain region.
1H NMR Spectroscopy
All experiments were performed on a 9.4 T/31cm magnet
(Magnex Scientific, Abingdon, UK) equipped with an
11-cm gradient coil (300 mT/m, 500 s) retrofitted with a
strong custom-designed shim coil (Magnex Scientific) with
second-order shim strengths up to 0.04 mT/cm2. The mag-
net was interfaced to a Varian INOVA console (Varian,
Palo Alto, CA). A quadrature transmit/receive surface RF
coil with two geometrically decoupled single-turn coils
with a 14 mm diameter each was used. All first- and
second-order shim terms were adjusted for each volume of
interest (VOI) based on a recently improved FASTMAP
method using EPI readout (16). The water signal was effi-
ciently suppressed by variable power RF pulses with op-
timized relaxation delays (VAPOR) (17). Localization was
performed using ultra-short echo-time STEAM (TE 2 ms,
TM  20 ms, TR  5 sec) with asymmetric RF pulses
combined with outer volume saturation (OVS) (17). The
displacement error was minimized by using broadband RF
pulses (13.5 kHz in STEAM, 35 kHz for OVS) combined
with field gradients of 100–200 mT/m for slice selection.
Data were acquired as a series of FIDs (consisting of
16 averages each) that were separately saved on a disk. The
FIDs were individually corrected for frequency drift, then
summed together and corrected for residual eddy current
effects using reference water signal (21). 1H NMR spectra
were acquired from the VOIs centered in hippocampus,
striatum, and cerebral cortex. The positions of VOIs were
based on RARE images (echo train length (ETL)  8, echo
spacing 12 ms, TE  48 ms, number of phase-encoding
steps  128, slice thickness  1 mm, number of transients
NT 2, TR 4 sec). The dimensions of VOIs were slightly
increased with age, in particular for hippocampus, to min-
imize potential partial volume effects in the developing
brain. In hippocampus the VOI ranged from 2.5  1.5 
3.0 mm3 to 3.0  2.0  3.0 mm3, in striatum from 3.0 
2.0  3.0 mm2 to 3.0  2.0  4.0 mm2, and in cortex from
4.0  1.5  3.0 mm3 to 4.0  1.5  4.0 mm3. Fully
automatic shimming, RF power, and water suppression
adjustment required less than 3 min per brain region. In
conjunction with the increased sensitivity at 9.4 T, this
allowed us to collect multislice images as well as spectra
from all three different locations and sufficient S/N within
100 min.
Quantification
1H NMR spectra were analyzed using LCModel (22) in-
cluding a macromolecule spectrum in the database, ac-
cording to previously described procedures (18). The un-
suppressed water signal, corrected for age-dependent
changes in brain water content, was used as an internal
reference. The brain water content was measured on P7,
P14, and P28 using the weight difference between freshly
removed brain and its residue after lyophilization. The
following 18 metabolites were quantified from each spec-
trum: alanine (Ala), aspartate (Asp), creatine (Cr), -ami-
nobutyric acid (GABA), glucose (Glc), glutamate (Glu),
glutamine (Gln), glutathione (GSH), glycerophosphoryl-
choline (GPC), phosphorylcholine (PCho), myo-inositol
(Ins), lactate (Lac), N-acetylaspartate (NAA), N-acetylas-
partylglutamate (NAAG), phosphocreatine (PCr), phos-
phorylethanolamine (PE), scyllo-inositol, and taurine
(Tau).
Statistical Analysis
The SPSS software package (SPSS, Chicago, IL) was used
for statistical analysis. The data for each metabolite were
first tested for a normal distribution (Kolmogorov-Smirnov
test) and then statistically analyzed by a multivariate anal-
ysis of variance (MANOVA) with post-hoc multiple com-
parison (Bonferroni). Finally, a Pearson correlation analy-
sis was performed.
RESULTS
Typical locations and sizes of the VOIs centered in hip-
pocampus, striatum, and cortex, which were selected for
spectroscopic studies, are shown in Fig. 1. In vivo 1H NMR
spectra from these three brain regions were acquired on
P7, P10, P14, P21, and P28. The 1H NMR spectra of the
developing rat hippocampus shown in Fig. 2 represent the
spectral quality observed routinely throughout this study
for this brain region. The increase of NAA, Glu, Ins, and
total creatine (Cr  PCr) and the decrease of Tau and PE
FIG. 3. a: Dependence of the brain water content on postnatal age.
Comparison of our experimental data with the data published by De
Souza and Dobbing (23). b: Macromolecule content in hippocam-
pus, striatum, and cerebral cortex of the developing rat brain.
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during postnatal brain development (clearly visible in Fig.
2) were consistently observed in all three brain regions.
The unsuppressed water signal from the VOI was used
for absolute metabolite quantification. Brain water con-
tents measured on P7, P14, and P28 (Fig. 3a) were in very
good agreement with previously published data (23). As in
previous studies, a small but significant decrease in brain
water content was observed during postnatal develop-
ment. The macromolecule content, which was quantified
from each spectrum as part of the LCModel analysis, was
found to be highly reproducible in all age groups and in all
three studied regions of the brain (coefficients of variation
10%) and showed a modest increase of approximately
30% during postnatal development (Fig. 3b).
An experimentally measured spectrum from the hip-
pocampus of a P28 rat was chosen as an example to illus-
trate the principle of LCModel analysis of short echo-time
1H NMR spectra measured at 9.4 T. (Fig. 4). In this analy-
sis, the in vivo spectrum of the brain was decomposed into
18 spectra of individual metabolites and the spectrum of
fast relaxing macromolecules included in the LCModel
database. The Cramer-Rao lower bounds (CRLB), which
are the estimates of the precision of the fitted concentra-
tions, were below 20% for most of the metabolites in all
age groups and in all three studied regions of the brain.
This corresponded to an estimated error of calculated con-
centration 0.2 mol/g. Taurine and total Cr were quan-
tified with CRLB  5% from all 114 processed spectra.
Only a few weakly represented metabolites, such as Ala,
Asp, and NAAG, were quantified with CRLB exceeding
20% in some age groups. Finally, CRLB 	 20% was found
for Ins in P7 rats, where the Ins concentration was below
0.5 mol/g. The results of the metabolite quantification in
three different regions (hippocampus, striatum, and cere-
bral cortex) of the developing rat brain are summarized in
Figs. 5 and 6. Scyllo-inositol, although included in the
LCModel database, was not further analyzed because it
was not detected in 50% of the processed spectra. In
addition, the sum of PCho and GPC was used to evaluate
the regional and developmental changes because of a
strong cross-correlation between PCho and GPC that arises
from the close spectral similarity (as illustrated in Fig. 4).
The concentration of glucose was 4–5 mol/g indepen-
dent of age and brain location. The sum of Cr and PCr is
FIG. 4. LCModel fit of a 1H NMR spectrum
measured from rat hippocampus on post-
natal day 28. In vivo spectrum (nonfiltered
FT), fitted spectrum, residual, model solu-
tion spectra of brain metabolites, and the
spectrum of fast-relaxing macromolecules
(Mac).
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also included in Fig. 6 for easier comparison with pub-
lished data.
The statistical distribution of data for each metabolite in
all three brain regions and all age groups was assessed to
be normal using a Kolmogorov-Smirnov test. Using
MANOVA with post-hoc multiple comparison statistical
analysis, brain metabolites were classified according to
developmental changes and regional differences (Table 1).
Significant differences between hippocampus, striatum,
and cerebral cortex for each postnatal age group were
found for Ins and GPC  PCho (P  0.01). For most of the
metabolites, the differences between locations became ap-
parent on P14 or later. The highest level of significance
(P 0.001) for the concentration differences of metabolites
between hippocampus, striatum, and cerebral cortex were
found for Asp, Ins, NAA, PE, Tau, and GPC  PCho. A
correlation analysis of metabolite concentration vs. post-
natal age, shown in the far right column of Table 1, indi-
FIG. 5. Concentration of brain metabolites in hippocampus, striatum, and cerebral cortex in the developing rat brain (P7–P28). Error bars
denote standard deviations.
28 Tka´cˇ et al.
cated that metabolites with the highest rates of concentra-
tion increase (	 0.10 mol g-1 day-1) between P7 and P28
were Glu, Ins, NAA, and PCr  Cr. The most rapid de-
crease in concentration over time (	 0.10 mol g-1 day-1)
was found for PE and Tau, whereas Asp, GABA, Glc, and
GSH did not correlate with postnatal age (P 	 0.05). How-
ever, Asp, GABA, NAAG, and Tau reached maximum con-
centration approximately on P14, as judged from the op-
posite signs of the correlation coefficients resulting from
correlation analysis of the subsets of data (P7–P14 vs.
P14–P28).
Interestingly, the ratios of [PCr]/[Cr] and [Glu]/[Gln] also
peaked between P14 and P21. The ratio [PCr]/[Cr] rose
from 0.5  0.2 (P7) to a maximum of 1.0  0.2 (P14–P21)
and decreased to 0.8  0.2 on day P28. The ratios of
[Glu]/[Gln] changed within a range of 2.0–4.5 and signif-
icant differences in [Glu]/[Gln] were found between loca-
tions (Fig. 7).
FIG. 6. Concentration of brain metabolites in hippocampus, striatum, and cerebral cortex in the developing rat brain (P7–P28). Error bars
denote standard deviations (continuation of Fig. 5).
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DISCUSSION
This study demonstrates that the postnatal development of
the rat brain can be measured longitudinally with high reli-
ability and reproducibility, indicating that very small
changes in the neurochemical profile can be detected. The
accuracy and reliability of metabolite concentrations quanti-
fied from in vivo 1H NMR spectra can be judged from Cra-
mer-Rao lower bounds provided by LCModel analysis. The
consistently low values of the CRLB (less than 20%) for most
of the metabolites included in the LCModel database for all
brain regions and age groups guaranteed high reliability of
quantified concentrations. For example, strongly represented
metabolites, such as Tau and Cr PCr, were quantified with
CRLB  5% from all 114 processed spectra. The interindi-
vidual coefficient of variation (CV) was below 5% for total Cr
and well below 10% for most metabolites (indicated by the
error bars in Figs. 5, 6, representing SD). The similarity of the
CRLB and CV implied that the variation between animals,
including water signal referencing, did not contribute signif-
icantly to the variation of metabolite concentrations. Such a
high reproducibility of the data, untypical for in vivo NMR
spectroscopy, was attributed to a number of factors: First, the
advantages of increased sensitivity and spectral resolution at
9.4 T were used to measure the neurochemical profiles in
three different locations of the developing rat brain. How-
ever, the strength of the magnetic field alone was not suffi-
cient to achieve this goal. Extremely powerful, custom-de-
signed second-order shim coils (0.04 mT/cm2), manufac-
tured by Magnex Scientific according to our specifications,
were used. The shim system was strong enough to correct for
second-order field inhomogeneities in measured brain re-
gions of P7 rat pups, where the overall demand was highest
and typically required 50–70% of available shim strength.
Automatic shim adjustment by FASTMAP (16) ensured a
high spectral resolution (water signal linewidth 8–12 Hz),
which routinely resulted in resolved signals of the methylene
groups of Cr and PCr (Figs. 2, 4). In addition, highly efficient
water suppression achieved with the VAPOR technique (17),
excellent localization performance of the sequence (STEAM
combined with OVS) (17), and minimization of the chemical
shift displacement error by using very strong slice selection
gradients further guaranteed high reproducibility of spectra
for the entire 1H chemical shift range. Finally, the ultra-short
echo-time of only 2 ms substantially minimized J-modula-
tion of the coupled spin systems and signal attenuation
caused by T2 relaxation, which simplified the quantification
of brain metabolites and eliminated effects of a potential
variation of T2 on metabolite quantification.
For several metabolites, such as Glu, Ins, Lac, NAA, and
Tau (shown in Fig. 4), characteristic spectral patterns were
easily discernible in all in vivo spectra (Fig. 2). Develop-
mental changes in concentrations of several metabolites,
such as NAA, Ins, Tau, Glu, PE, and total Cr, were evident
from a visual inspection of the 1H NMR spectra (Fig. 2).
Concentration changes of weakly represented metabolites,
such as GABA or Gln, were not as obvious; however, they
can be estimated taking into account contributions of over-
lapping resonances in specific spectral regions. For exam-
ple, only limited developmental concentration changes of
GABA can be expected by inspection of the signal inten-
sity at 2.28 ppm (Fig. 2), taking into account the signal
contribution from macromolecules. Similarly, the signal
intensity at 2.44 ppm (Fig. 2) indicates only a moderate
increase in Gln concentration during postnatal brain de-
velopment, taking into account the signal overlap of H-4 of
Gln with one of the geminal CH2 protons of NAA at
2.49 ppm. However, a precise quantification requires so-
phisticated fitting analysis, such as LCModel, even at
9.4 T. An example of LCModel spectral analysis is illus-
trated in Fig. 4, which shows contributions of the charac-
teristic spectra of each individual metabolite included in
the database.
FIG. 7. Developmental changes of the glutamate/glutamine ratio in
hippocampus, striatum, and cerebral cortex.
Table 1
Schematic Representation of the Differences in Metabolite
Concentrations Between Hippocampus, Striatum, and Cerebral
Cortex and the Type of Concentration Changes During Postnatal
Brain Development
Metabolite
Differences between locationsa Changes
with agebP7 P10 P14 P21 P28
Mac 1
Ala 1
Asp
Cr 11
PCr 11
GABA
Glc
Gln 11
Glu 111
GSH
Ins 111
Lac
NAA 111
NAAG 2
PE 222
Tau 222
GPC  PCho 2
Cr  PCr 111
P  0.05 P  0.01 P  0.001
aShaded areas demonstrate differences in metabolite concentration
between brain location (hippocampus, striatum, cerebral cortex) at
three significance levels.
bArrows indicate significant concentration increase (mol g
1day
1):
1  0.05, 11 0.05–0.10, 111 	 0.10; or significant concen-
tration decrease (mol g
1 day
1): 2  0.05, 22 0.05–0.10,
222 	 0.10; during brain development.
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The majority of the observed developmental changes of
the neurochemical profile of the rat brain (Figs. 5, 6, Table
1), specifically the increase of NAA, Glu, Gln, and total Cr,
as well as the decrease of PCho  GPC, PE, and Tau, are in
agreement with previously published data of brain extracts
(6–11,13,24,25). Minor developmental changes in concen-
trations observed for GABA and NAAG are also in agree-
ment with previously published data (8,9).
Unfortunately, a survey of published metabolite concen-
trations in the developing rat brain indicates a rather broad
range (8–14,24–28). Interestingly, the results of classic
biochemical assays published by different laboratories
more than two decades ago show a close agreement to
within 10% (8,9,24–27). Therefore, we compared our in
vivo data to the in vitro data published in the aforemen-
tioned articles. Absolute metabolite concentrations (in
mol/g) presented in Figs. 5 and 6 were in very good
agreement with the in vitro data (Table 2). For example,
the concentration of Tau in hippocampus, striatum, and
cortex of a 7-day-old rat ranged in our study between
12–13 mol/g, which is identical to the range of data
published by several different laboratories (24–27). Small
differences for some of the other metabolites can be ex-
plained by regional variation in the neurochemical com-
position of the brain tissues (28) as well as the effects of the
catabolic reactions of metabolites in biochemical in vitro
assays. Further, paired studies comparing metabolite con-
centrations in specific brain regions measured by in vivo
NMR and by the analysis of brain extract analysis are
needed to determine to what extent the regional variation,
postmortem processes, or inaccuracies of the methods
used can account for the differences.
Significant differences between hippocampus, striatum,
and cerebral cortex were found for most of the metabolites
(Table 1). Specific patterns of regional differences in me-
tabolite concentrations were consistently detected during
postnatal brain maturation, especially for P14, P21, and
P28. Examples of regional differences include Glu being
highest in cortex, NAA lowest in striatum, Ins highest in
hippocampus, and the choline compounds highest in stri-
atum. This resulted in a characteristic neurochemical pro-
file for each studied brain region that cannot be explained
either by regional differences in gray/white matter ratios or
by differences in water content, which was used as inter-
nal reference for quantification. For most compounds, re-
gional differentiation started on postnatal day P14 (sum-
marized in Table 2), coinciding with the period (P10–P17)
of active brain growth, myelination, and rapid increase in
cerebral energy metabolism (29). These, in turn, are asso-
ciated with the acquisition of the specific brain functions,
such as audition (P10–P14) and vision and locomotion
(P14–P17) (30). The observed differences in neurochemi-
cal profiles between locations are not surprising, consid-
ering the variable populations of different neural cell types
characterized by the specific chemical composition (31).
To what extent regional differences in metabolism also
contributed to the different neurochemical profiles re-
mains to be determined. Changes of Glc and Lac were not
interpreted, because their concentrations can depend on
the anesthesia regimen, which is outside of the scope of
the current study.
The 2-fold increase in [PCr]/[Cr] ratio during postnatal
brain development (P7–P21) coincided with the 4-fold
increase in creatine kinase activity between P12 and P17
(32). The ratio of [Glu]/[Gln] depended on location and age
(Fig. 7) and interestingly peaked between P14 and P21.
The [Glu]/[Gln] ratio in normal brain is an important pa-
rameter, because Glu and Gln metabolism in the brain is
closely related to neurotransmission and Glu and Gln cy-
cling between neurons and glia (33,34). In addition, the
decrease in [Glu]/[Gln] ratio from a normal value for a
specific brain region and age is assumed to be a marker of
a metabolic defect (35,36).
The in vivo measurement of the neurochemical profile
using NMR spectroscopy has several advantages, such as
elimination of effects related to animal termination and
brain extraction and the possibility of a longitudinal ex-
perimental design resulting in substantial reduction of
required animals. Previously, only a limited number of
metabolites (NAA, Cho, total Cr, PCr, PE) have been mea-
sured in developing rat brain using either in vivo 1H or 31P
NMR spectroscopy (12–14). In the present study, several
metabolites key to brain development (e.g., PE and PCr),
until now only accessible in 31P NMR spectra, were de-
tected and quantified using 1H NMR spectroscopy. The
excellent agreement of our data with the results of brain
extract analysis indicated that at least 16 metabolites can
be reliably quantified with high accuracy and precision in
specific regions of the developing rat brain using in vivo
1H NMR spectroscopy at 9.4 T.
We conclude that in vivo 1H NMR spectroscopy at high
magnetic fields, based on powerful shimming, efficient
Table 2
Comparison of the Measured Metabolite Concentrations in Developing Rat Brain With the Literature Data
Metabolite
P7 P28
Reference
This studya Literature This studya Literature
Asp 1.0–1.3 2.0–2.5 1.2–2.4 2.5–3.8 8,24
GABA 0.7–1.0 1.1–1.3 0.9–1.1 1.3–1.7 8,24
Gln 1.3–1.7 3.0–4.3 2.8–3.5 3.8–4.7 8,24
Glu 3.2–3.5 5.8–6.5 8.7–11.2 9.0–9.5 8,24
NAA 0.7–0.8 1.5–2.5 7.6–10.0 4.7–9.0 9,11
PE 4.9–5.4 3.6–8.0 2.1–2.8 1.7–4.0 11,24
Tau 12.0–13.0 12.0–13.0 8.1–10.8 5.0–7.4 24–27
Cr  PCr 5.7 5.2–6.5 8.3–9.0 8.5–9.7 11
Concentrations are expressed in units mol/g.
aRanges of averaged concentrations from hippocampus, striatum, and cerebral cortex.
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water suppression, high-performance localization pulse
sequence, and LCModel fitting can accurately measure the
neurochemical profile in specific regions of the developing
rat brain. Because the current study design was longitudi-
nal and completely noninvasive, this approach can be
extended to study human brain development taking into
account the availability of whole-body 7 T systems (37).
Given the wide variability in rates of regional brain growth
and the differential vulnerability of brain regions to met-
abolic insults early in life (19,20), such detailed neuro-
chemical information is likely to provide new insight into
the neurochemical processes of normal and pathologic
brain development and to monitor the response to thera-
pies.
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